genprowebdirectory
GEN Edge
News
Insights
Trends for 2021
Trends for 2020
A-Lists
Topics
Bioprocessing
Cancer
Drug Discovery
OMICs
Translational Medicine
Genome Editing
Magazine
Resources
All
GEN Live
Posters
Videos
Webinars
eBooks
Podcasts
Events
New Products
Tutorial
Best of the Web
Best Apps
Subscribe
Create a Free Account
Get GEN Edge
Log In
Get GEN Magazine
Get GEN eNewsletters
Get the GEN Mobile App
Get GEN News from Alexa
Search
Advertising
Magazine Advertising
Website Banner Advertising
eNewsletter Advertising
Webinar Sponsorship
eBook Advertising
Email Nurture Campaigns
Ad Terms and Conditions
About GEN
Contact GEN
Create a Free Account
Get GEN Edge
Log In
GEN – Genetic Engineering and Biotechnology News
Mary Ann Liebert, Inc. Publishers
GEN Edge
Gene Therapy
Bayer Approach to Partnerships, Pipelines, and Platforms
Genomics
Genomics in the Clinic: A Candid Conversation with Sema4 CEO Eric…
Circulating Tumor Cell
Illumina Launching Pan-Cancer IVD Test, Cloud-Based Bioinformatics Platform
Biomarkers
Guardant Health Launches Early-Stage Colorectal Cancer ctDNA Assay
GEN Edge
EY Firepower Report: Biopharma M&A Poised to Rebound in 2021
News
Antisense
Antisense Oligo Targets IRF4 Gene to Treat Multiple Myeloma
Drug Discovery
Novel Promising Anti-Fungal Compound Identified in Ant Nests
Cancer
Promising Triple Therapy Approach Identified for Renal Cell Carcinoma
Neuroscience
Deep Sleep Aids in Neurodegenerative Disease Prevention
Cancer
Mathematical Model Captures Relationship between Speed and Surface in Cell Movement
Insights
All
Trends for 2021
Trends for 2020
Bioprocessing
Biopharma Manufacturers Shouldn’t Rush When “Going Digital”
Bioprocessing
Separating Cells with Microfluidics
Trends for 2021
Beyond 2021: Cell Therapy Manufacturing Trends
Bioprocessing
Machine Learning for Better Bioprocess Data Analysis
A-Lists
January 2021 Vol. 41 No. 1
Seven Biopharma Trends to Watch in 2021
A-Lists
Top 15 Best-Selling Drugs Launched in 2020
A-Lists
Top 50 NIH-Funded Institutions of 2020
July 2020 Vol. 40 No. 7
Top 10 Earners among Women Biopharma Executives
June 2020 Vol. 40 No. 6
In Praise of Lesser-Sung Life Sciences Clusters
Topics
All
Bioprocessing
Cancer
Drug Discovery
OMICs
Translational Medicine
Genome Editing
Antisense
Antisense Oligo Targets IRF4 Gene to Treat Multiple Myeloma
Drug Discovery
Novel Promising Anti-Fungal Compound Identified in Ant Nests
Cancer
Promising Triple Therapy Approach Identified for Renal Cell Carcinoma
Cancer
Mathematical Model Captures Relationship between Speed and Surface in Cell Movement
Magazine
January 2021 Vol. 41 No. 1
Seven Biopharma Trends to Watch in 2021
January 2021 Vol. 41 No. 1
Leroy Hood: Reflections on a Legendary Career
January 2021 Vol. 41 No. 1
COVID-19 One Year Later: The Biology and the Business
Traditional Medicine
Monoclonal Antibodies: Developers Explore New Territories
Roundtable
Uncharted Territory: Top Challenges Facing Gene Therapy Development
Resources
All
GEN Live
Posters
Videos
Webinars
eBooks
Podcasts
Events
New Products
Tutorial
Best of the Web
Best Apps
Subscribe
Create a Free Account
Get GEN Edge
Log In
Get GEN Magazine
Get GEN eNewsletters
Get the GEN Mobile App
Get GEN News from Alexa
Home
RNA
RNAi
RNAi
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
RNAi
RNA Drugs Can Escape Endosomal Confinement, Tumor Spheroids Confirm
RNAi
Dicerna, Novo Nordisk Eye 30+ Liver Targets in Up-to-$3.8B RNAi Partnership
RNAi
Anticancer siRNAs Delivered to Cells Using MOF Nanoparticles
RNAi
Atherosclerosis Could Be Reversed by Nanoparticle-Encapsulated RNAi Drug
RNAi
Anti-Aging Drug Candidates ID’d Using Transcriptomes of Long-Lived Worms
RNAi
Silencing Genes in Cellular Protein Factories Amplifies Production
RNAi
Alnylam, Regeneron Launch $1B RNAi Collaboration Focused on Eye, CNS, Liver...
RNAi
Genetically Modified Pigs May Prevent Bacon Shortages
RNAi
RNAi Therapy for Preeclampsia is Pregnant with Possibility
RNAi
RNAi Shares Discovery Spotlight with CRISPR-Cas
RNAi
Lilly, Dicerna Launch $3.7B+ RNAi Collaboration
RNAi
Alexion, Dicerna Launch $637M+ RNAi Collaboration in Complement-Mediated Diseases
RNAi
FDA Approves Alnylam’s Onpattro for Polyneuropathy of hATTR Amyloidosis
RNAi
Autism Genetic Complexity Comes to Light
RNAi
Regeneron, Alnylam to Pursue RNAi Treatments for NASH
Load more
Scroll Up
We use cookies to give you a better experience on genengnews.com. By continuing to use our site, you are agreeing to the use of cookies as set in our
privacy policy.
Got it!
Edit with Live CSS
/* The alert message box */ .alert { padding: 20px; background-color: #ff9800; /* Red */ color: white; margin-bottom: 15px; } /* The close button */ .closebtn { margin-left: 15px; color: white; font-weight: bold; float: right; font-size: 22px; line-height: 20px; cursor: pointer; transition: 0.3s; } /* When moving the mouse over the close button */ .closebtn:hover { color: black; } .td_module_flex_2 .entry-title { font-size: 17px; line-height: 20px; }
![Illustration of chromosome 16 showing the 14 fly counterparts of the 25 human genes located in a deletion on the chromosome that is associated with autism risk. Researchers used RNA interference (RNAi) to the reduce the expression of these genes individually and in tandem to test how the interactions of these genes modulate neurodevelopmental symptoms associated with the deletion. Interactions between genes that either enhance or suppress the affect of reduced expression are shown by red or blue lines. [Girirajan Laboratory/Penn State]](https://www.genengnews.com/wp-content/uploads/2018/08/Jul2_2018_PennState_Chromosome16Ilustration4113701011-324x160.jpg "Autism Genetic Complexity Comes to Light")
![C. elegans. [Source: Arturo Agostino]](https://www.genengnews.com/wp-content/uploads/2018/08/169244_web1201231412-265x198.jpg "Anti-Aging Drug Candidates ID’d Using Transcriptomes of Long-Lived Worms")